PFIZER INC — Director's Dealing 2009

Oct 19, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-10-15

Reporting Person: MASCOTTE JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-15	Common Stock	A	3940	—	Acquired	3940	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-15	Phantom Stock Units	$	A	5500	Acquired		Common Stock (5500)	Direct

Footnotes

F1: Received (together with $33.00 in cash for each share of Wyeth common stock) in exchange for 4,000, shares of Wyeth common stock in connection with the acquisition of Wyeth by Pfizer Inc. (the "Acquisition"). On the closing date of the Acquisition, the closing price of Wyeth's common stock was $50.39 per share.

F2: Each unit represents one phantom share of common stock.

F3: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F4: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.